Venus Remedies Limited (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Venus Remedies Limited (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Venus Remedies Limited (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Venus Remedies Limited (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
23 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Venus Remedies Limited (Venus) is a pharmaceutical company that develops, manufactures and commercializes pharmaceutical products. The company, through its research centre Venus Medicine Research Centre, provides novel solutions for unmet medical needs in the fields of oncology, anti-microbial resistance, wound care and pain management. Its product portfolio includes Elores, Vancoplus, Potentox, Tobracef, Supime, Zydotum, and Pirotum, among others. Venus's products are used in various therapeutic areas such as anti cancer, anti infective, neurology, skin & wound care, and pain management, neurology and OTC.

Venus Remedies Limited (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major r

  
Source:
Document ID
GDPH35535D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Venus Remedies Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Venus Remedies Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Venus Remedies Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Venus Remedies Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Venus Remedies Limited, Medical Devices Deals, 2010 to YTD 201691
Venus Remedies Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Venus Remedies Limited, Pharmaceuticals &Healthcare, Deal Details119
  Partnerships111
    Venus Remedies Enters into Agreement with Teva Pharma for Anti Cancer Drug111
    Venus Pharma Enters Into Co-Marketing Agreement With Mylan For Meropenem121
    Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox131
  Licensing Agreements141
    Venus Remedies May Enter into Licensing Agreement with Europe and US Company141
    Venus Pharma Enters into Licensing Agreement with Mylan for Meropenem151
    Venus Remedies to Enter into License Agreement with Austell Lab for Elores161
    Venus Remedies Enters Into Licensing Agreement With Goodwills For Elores171
  Equity Offering181
    Venus Remedies Plans Private Placement Of Shares For Up To US$30 Million181
    Venus Remedies Completes Private Placement Of Shares For US$3.7 Million Upon Exercise Of Warrants191
Venus Remedies Limited - Key Competitors201
Key Employees211
Locations And Subsidiaries221
  Head Office221
  Other Locations &Subsidiaries221
Appendix231
  Methodology231
  About GlobalData231
  Contact Us231
  Disclaimer231

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Venus Remedies Limited (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Venus-Remedies-Limited-VENUSREM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7848>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Venus Remedies Limited (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Venus-Remedies-Limited-VENUSREM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7848>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research